Jacob Plieth· @JacobPlieth · X·· 2 days agoScore90
Body
I expect various sellsiders will be firefighting $MRNA today, but that's a very measured take from Evercore ISI's Cory Kasimov. Good to see! #Esmo26
5056 views · 9 likes · 0 reposts · 2 replies
Conference abstracts
Impact of BRAF V600K mutation in patients with resectable stage III melanoma: A subgroup analysis of the NADINA trial
https://esmocongress.esmo.orgReplies in this thread
- BadInvestor9@badinvestor99
@JacobPlieth @A_May_MD What does he know? It’s a cure for all cancers. You just don’t see it yet.
- Jacob Plieth@JacobPlieth
Cory Casimov citing KOL re $MRNA: Patient mix matters; Neoadjuvant comps matter - cited Nadina & SWOG S1801 cc @A_May_MD; Uncertainty around OS (could change with mature data); Approval ≠ universal uptake. #Esmo26
Source: Jacob Plieth · x.com